Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$0.23 - $0.33 $6,006 - $8,617
-26,115 Closed
0 $0
Q2 2019

Aug 09, 2019

SELL
$0.26 - $0.4 $10,407 - $16,012
-40,030 Reduced 60.52%
26,115 $8,000
Q1 2019

May 15, 2019

SELL
$0.35 - $0.5 $9,004 - $12,864
-25,728 Reduced 28.0%
66,145 $26,000
Q4 2018

Feb 14, 2019

BUY
$0.36 - $0.59 $8,708 - $14,272
24,190 Added 35.74%
91,873 $49,000
Q3 2018

Nov 13, 2018

BUY
$0.37 - $0.46 $25,042 - $31,134
67,683 New
67,683 $28,000

About Arch Therapeutics, Inc.


  • Ticker ARTH
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,886,000
  • Market Cap $50M
  • Description
  • Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flag...
More about ARTH
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.